Jacobs Levy Equity Management, Inc Aclaris Therapeutics, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $25.8 Billion
- Q4 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 576,042 shares of ACRS stock, worth $1.34 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
576,042
Previous 915,509
37.08%
Holding current value
$1.34 Million
Previous $1.03 Million
38.1%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ACRS
# of Institutions
99Shares Held
80.7MCall Options Held
257KPut Options Held
92.3K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$33.2 Million21.95% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$22.4 Million0.04% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$20.7 Million4.3% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD6.2MShares$14.5 Million0.61% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.67MShares$10.9 Million0.19% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $155M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...